{"id":23577,"date":"2024-12-11T08:46:01","date_gmt":"2024-12-11T13:46:01","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/ppb\/?post_type=profile&#038;p=23577"},"modified":"2024-12-13T10:28:01","modified_gmt":"2024-12-13T15:28:01","slug":"kimberley-steen","status":"publish","type":"profile","link":"https:\/\/www.bumc.bu.edu\/ppb\/profile\/kimberley-steen\/","title":{"rendered":"Kimberly Steen"},"content":{"rendered":"<p><strong>Program:<\/strong> Ph.D. Biomolecular Pharmacology\/Pfizer<br \/>\n<strong>Advisor:<\/strong> Rachel Flynn, Ph.D.<br \/>\n<strong>Research Summary:<\/strong> Kimberly is interested in understanding the mechanism of pathogenesis in metabolic disease such as CKM (cardiovascular-kidney-metabolic syndrome), including discerning the metabolic microenvironment and how some pathological states persist over time even after intervention.<\/p>\n","protected":false},"author":1811,"template":"","_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/profile\/23577"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/profile"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/types\/profile"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/users\/1811"}],"version-history":[{"count":4,"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/profile\/23577\/revisions"}],"predecessor-version":[{"id":23594,"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/profile\/23577\/revisions\/23594"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/media?parent=23577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}